Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas.

Trucco MM, Meyer CF, Thornton KA, Shah P, Chen AR, Wilky BA, Carrera-Haro MA, Boyer LC, Ferreira MF, Shafique U, Powell JD, Loeb DM.

Clin Sarcoma Res. 2018 Nov 5;8:21. doi: 10.1186/s13569-018-0107-9. eCollection 2018.

2.

Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.

Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, Savasan S, Hudspeth MP, Adams RH, Lewis VA, Kheradpour A, Kasow KA, Gillio AP, Haight AE, Bhatia M, Bambach BJ, Haines HL, Quigg TC, Greiner RJ, Talano JM, Delgado DC, Cheerva A, Gowda M, Ahuja S, Ozkaynak M, Mitchell D, Schultz KR, Fry TJ, Loeb DM, Pulsipher MA.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2040-2046. doi: 10.1016/j.bbmt.2018.06.010. Epub 2018 Jun 19.

PMID:
29933069
3.

Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.

Llosa NJ, Cooke KR, Chen AR, Gamper CJ, Klein OR, Zambidis ET, Luber B, Rosner G, Siegel N, Holuba MJ, Robey N, Hayashi M, Jones RJ, Fuchs E, Holdhoff M, Loeb DM, Symons HJ.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2127-2136. doi: 10.1016/j.bbmt.2017.08.012. Epub 2017 Aug 12.

4.

Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.

Klein OR, Buddenbaum J, Tucker N, Chen AR, Gamper CJ, Loeb D, Zambidis E, Llosa NJ, Huo JS, Robey N, Holuba MJ, Kasamon YL, McCurdy SR, Ambinder R, BolaƱos-Meade J, Luznik L, Fuchs EJ, Jones RJ, Cooke KR, Symons HJ.

Biol Blood Marrow Transplant. 2017 Feb;23(2):325-332. doi: 10.1016/j.bbmt.2016.11.016. Epub 2016 Nov 22.

5.

High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.

Gamper CJ, Takemoto CM, Chen AR, Symons HJ, Loeb DM, Casella JF, Dezern AE, King KE, McGonigle AM, Jones RJ, Brodsky RA.

J Pediatr Hematol Oncol. 2016 Nov;38(8):627-635.

6.

Tolerance and effectiveness of nivolumab after pediatric T-cell replete, haploidentical, bone marrow transplantation: A case report.

Shad AT, Huo JS, Darcy C, Abu-Ghosh A, Esposito G, Holuba MJ, Robey N, Cooke KR, Symons HJ, Chen AR, Llosa NJ.

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26257. Epub 2016 Sep 21.

PMID:
27650634
7.

A Model for the Departmental Quality Management Infrastructure Within an Academic Health System.

Mathews SC, Demski R, Hooper JE, Biddison LD, Berry SA, Petty BG, Chen AR, Hill PM, Miller MR, Witter FR, Allen L, Wick EC, Stierer TS, Paine L, Puttgen HA, Tamargo RJ, Pronovost PJ.

Acad Med. 2017 May;92(5):608-613. doi: 10.1097/ACM.0000000000001380.

PMID:
27603038
8.

Improved Behavior and Neuropsychological Function in Children With ROHHAD After High-Dose Cyclophosphamide.

Jacobson LA, Rane S, McReynolds LJ, Steppan DA, Chen AR, Paz-Priel I.

Pediatrics. 2016 Jul;138(1). pii: e20151080. doi: 10.1542/peds.2015-1080. Epub 2016 Jun 16.

9.

Persistent Multiyear Control of Relapsed T-Cell Acute Lymphoblastic Leukemia With Successive Donor Lymphocyte Infusions: A Case Report.

Huo JS, Symons HJ, Robey N, Borowitz MJ, Schafer ES, Chen AR.

Pediatr Blood Cancer. 2016 Jul;63(7):1279-82. doi: 10.1002/pbc.25971. Epub 2016 Mar 14.

10.

Automated Functional Imaging by 2D Speckle Tracking Echocardiography Reveals High Incidence of Abnormal Longitudinal Strain in a Cohort of Pediatric Oncology Patients.

Tran JC, Ruble K, Loeb DM, Chen AR, Thompson WR.

Pediatr Blood Cancer. 2016 Jun;63(6):1075-80. doi: 10.1002/pbc.25938. Epub 2016 Feb 10.

PMID:
26864479
11.

Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders.

Klein OR, Chen AR, Gamper C, Loeb D, Zambidis E, Llosa N, Huo J, Dezern AE, Steppan D, Robey N, Holuba MJ, Cooke KR, Symons HJ.

Biol Blood Marrow Transplant. 2016 May;22(5):895-901. doi: 10.1016/j.bbmt.2016.02.001. Epub 2016 Feb 6.

12.

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.

Williams KM, Ahn KW, Chen M, Aljurf MD, Agwu AL, Chen AR, Walsh TJ, Szabolcs P, Boeckh MJ, Auletta JJ, Lindemans CA, Zanis-Neto J, Malvezzi M, Lister J, de Toledo Codina JS, Sackey K, Chakrabarty JL, Ljungman P, Wingard JR, Seftel MD, Seo S, Hale GA, Wirk B, Smith MS, Savani BN, Lazarus HM, Marks DI, Ustun C, Abdel-Azim H, Dvorak CC, Szer J, Storek J, Yong A, Riches MR.

Bone Marrow Transplant. 2016 Apr;51(4):573-80. doi: 10.1038/bmt.2015.316. Epub 2016 Jan 4.

13.

Higher Trophic Levels Overwhelm Climate Change Impacts on Terrestrial Ecosystem Functioning.

Pelini SL, Maran AM, Chen AR, Kaseman J, Crowther TW.

PLoS One. 2015 Aug 20;10(8):e0136344. doi: 10.1371/journal.pone.0136344. eCollection 2015.

14.

Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders.

Gorgy AI, Jonassaint NL, Stanley SE, Koteish A, DeZern AE, Walter JE, Sopha SC, Hamilton JP, Hoover-Fong J, Chen AR, Anders RA, Kamel IR, Armanios M.

Chest. 2015 Oct;148(4):1019-1026. doi: 10.1378/chest.15-0825.

15.

Bringing central line-associated bloodstream infection prevention home: catheter maintenance practices and beliefs of pediatric oncology patients and families.

Rinke ML, Chen AR, Milstone AM, Hebert LC, Bundy DG, Colantuoni E, Fratino L, Herpst C, Kokoszka M, Miller MR.

Jt Comm J Qual Patient Saf. 2015 Apr;41(4):177-85.

16.

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.

Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL.

J Clin Oncol. 2014 Nov 10;32(32):3651-8. doi: 10.1200/JCO.2013.52.5410. Epub 2014 Oct 13.

17.

WT1 regulates angiogenesis in Ewing Sarcoma.

Katuri V, Gerber S, Qiu X, McCarty G, Goldstein SD, Hammers H, Montgomery E, Chen AR, Loeb DM.

Oncotarget. 2014 May 15;5(9):2436-49.

18.

Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantation.

Shah NN, Borowitz MJ, Steinberg SM, Robey NC, Gamper CJ, Symons HJ, Loeb DM, Wayne AS, Chen AR.

Biol Blood Marrow Transplant. 2014 Jul;20(7):1033-9. doi: 10.1016/j.bbmt.2014.03.028. Epub 2014 Mar 30.

19.

Feasibility of treating post-transplantation minimal residual disease in children with acute leukemia.

Shah NN, Borowitz MJ, Robey NC, Gamper CJ, Symons HJ, Loeb DM, Wayne AS, Chen AR.

Biol Blood Marrow Transplant. 2014 Jul;20(7):1000-7. doi: 10.1016/j.bbmt.2014.03.021. Epub 2014 Mar 27.

20.

Central line maintenance bundles and CLABSIs in ambulatory oncology patients.

Rinke ML, Bundy DG, Chen AR, Milstone AM, Colantuoni E, Pehar M, Herpst C, Fratino L, Miller MR.

Pediatrics. 2013 Nov;132(5):e1403-12. doi: 10.1542/peds.2013-0302. Epub 2013 Oct 7.

Supplemental Content

Loading ...
Support Center